• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:
0

Cell & Gene Therapy

trojan horse
Research

Ernexa's stem cell therapy shrinks ovarian tumors in mice

The cells were engineered to produce two proinflammatory cytokines, IL-7 and IL-15, which help T cells infiltrate and fight tumors.
Darren Incorvaia Jun 2, 2025 2:30pm
rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm
embryonic stem cells

ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma

May 31, 2025 8:00am
liver

Intellia stock sinks on gene therapy patient's raised enzymes

May 29, 2025 9:15am
Graphic image of someone plucking out a portion of DNA with tweezers symbolizing gene editors

Gene editing leaders call for 10-year ban on heritable edits

May 28, 2025 7:00am
Make a delay and accumulation of outstanding tasks Full stop

Rocket crashes as gene therapy patient dies, FDA imposes hold

May 27, 2025 9:49am
More News

RegenXBio sells $250M of paydays for Zolgensma, other therapies

May 20, 2025 7:15am

CRISPR Tx, Sirius pen collab with a focus on thrombotic disease

May 20, 2025 3:59am

Gene editor shelves sole clinical asset, lays off 25% of staff

May 19, 2025 2:28pm

Atsena gene therapy hits safety goals, closes retinal splits

May 19, 2025 12:59pm
See more stories

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings